Tilray Brands, Inc. (TLRY)
Automate Your Wheel Strategy on TLRY
With Tiblio's Option Bot, you can configure your own wheel strategy including TLRY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
Why Tilray Brands Investors Shouldn't Expect the Company to Post a Profit Anytime Soon
Published: April 06, 2026 by: The Motley Fool
Sentiment: Neutral
Tilray has been acquiring beverage brands in recent years, and that continues to be part of its growth strategy. The business has become bigger, but its margins remain fairly low.
Read More
Tilray Brands Is Looking Better
Published: April 02, 2026 by: Seeking Alpha
Sentiment: Neutral
Tilray Brands (TLRY) remains a Hold, with valuation near tangible book value and a mixed Q3 showing revenue growth but margin pressure. Strength in cannabis and distribution segments offset weak beverage sales, while international cannabis revenue soared 73% in Q3, now 37% of segment revenue. Adjusted EBITDA guidance for FY26 is $62–$72 million, with consensus FY28 margin expectations at 9.5%, but cash flow remains negative and M&A execution is a risk.
Read More
Tilray Brands' strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish
Published: April 02, 2026 by: Proactive Investors
Sentiment: Positive
Tilray Inc (NASDAQ:TLRY) earned a repeat ‘Buy' rating from Jefferies analysts after what it described as a solid third quarter earnings report, pointing to improving fundamentals and increased visibility into the company's medium-term outlook. The brokerage reiterated a price target of $24, implying substantial upside if execution continues as expected.
Read More
Tilray Brands, Inc. (TLRY) Q3 2026 Earnings Call Transcript
Published: April 01, 2026 by: Seeking Alpha
Sentiment: Neutral
Tilray Brands, Inc. (TLRY) Q3 2026 Earnings Call Transcript
Read More
Deep dive: why Tilray stock sell-off despite record revenue makes sense
Published: April 01, 2026 by: Invezz
Sentiment: Negative
Tilray Brands (NASDAQ: TLRY) is seeing pressure this morning even after reporting an 11% year on year increase in revenue to a record $207 million for its third financial quarter. The price action may be puzzling to some, given the release signalled improving profitability and strong international cannabis growth as well.
Read More
Tilray Sinks 4%: 3 Reasons the Market Isn't Impressed Despite Record Q3 Revenue
Published: April 01, 2026 by: 24/7 Wall Street
Sentiment: Negative
Tilray Brands (NASDAQ:TLRY) shares declined 4% in Wednesday morning trading, falling to around $6.20 after opening at $6.47.
Read More
Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing?
Published: March 31, 2026 by: Zacks Investment Research
Sentiment: Neutral
TLRY heads into Q3 FY26 earnings with projected revenues up 10.9% and narrower losses, but margin pressure in cannabis and beverages clouds the outlook.
Read More
Best Canadian Cannabis Stocks for Potential Breakouts in March 2026
Published: March 31, 2026 by: MarijuanaStocks
Sentiment: Positive
The Canadian cannabis sector continues evolving as global opportunities expand. Many companies are now positioning for U.S. entry. Additionally, federal reform discussions in the United States remain a major catalyst. As a result, investors are closely watching key Canadian names. However, volatility remains high, so proper risk management is essential.
Read More
Don't Even Think About Buying Tilray Stock Until You Read This Warning
Published: February 22, 2026 by: The Motley Fool
Sentiment: Neutral
Tilray has been expanding beyond marijuana to include hemp products and alcoholic beverages. The company's strategy has led to top-line growth, but it has yet to generate sustainable profits.
Read More
Canadian Marijuana Stock Picks For Investors 2026
Published: February 20, 2026 by: MarijuanaStocks
Sentiment: Positive
There have been many changes and phases to legal cannabis around the globe. With the USA being the biggest market and Canada becoming the first to outright legalize the plant. This has been a slow uphill climb as laws and regulatory matters have made things anything but easy. However, this has not deterred potential investors from seeing an opportunity. Marijuana stocks have offered the average investor or person a chance to enter the space.
Read More
3 Canadian Marijuana Stocks Today's Stock Market That Could Soon Run
Published: February 04, 2026 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industry. For most marijuana stock investors, this is the area where shareholders tend to focus. Investors know that a company is doing well, or is working towards a significant goal, which can all lead to profitability. There are different sectors and markets to pay attention to.
Read More
Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced
Published: February 03, 2026 by: GlobeNewsWire
Sentiment: Neutral
Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Terrapin Beer Co., and Atwater Brewery Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Terrapin Beer Co., and Atwater Brewery
Read More
TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now?
Published: January 30, 2026 by: Zacks Investment Research
Sentiment: Positive
Tilray Brands' international revenue surge, beverage scale and strong cash position give it an edge over Canopy Growth as cannabis regulation and demand continue to evolve.
Read More
Tilray Has Already Done The Hard Part
Published: January 28, 2026 by: Seeking Alpha
Sentiment: Positive
Tilray is strategically positioned to benefit from U.S. cannabis reform, leveraging its diversified international and U.S. beverage operations. International medical cannabis, especially in Europe, drives TLRY's growth and margin stability, with Germany and Italy as key markets. Profitability hinges on sustained double-digit international growth, normalized interest and restructuring costs, and EBITDA consistently covering capital needs.
Read More
February 2026 Watchlist: Leading Canadian Cannabis Stocks
Published: January 27, 2026 by: MarijuanaStocks
Sentiment: Positive
The Canadian cannabis sector continues evolving as companies adapt to shifting consumer demand and global regulations. While volatility remains common, long-term opportunities still attract patient investors. Moreover, potential U.S. federal reform continues to influence sentiment across Canadian operators. Many Canadian companies maintain indirect exposure to the U.S. cannabis market through branding, distribution, and strategic investments. As a result, these stocks often move in step with U.S. multi-state operators during major policy headlines.
Read More
Tilray Brands' Bullish Beverage Strategy: What's Behind the Optimism?
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
TLRY's Beverage unit faces near-term pressure, but Project 420 savings, brand resets and global expansion underpin its long-term bullish view.
Read More
How Tilray Brands Is Acting on Its Vast International Opportunity
Published: January 20, 2026 by: Zacks Investment Research
Sentiment: Positive
TLRY posts a standout international quarter as cannabis revenues jump 36% year over year, driving supply shifts and broader global expansion.
Read More
3 Canadian Marijuana Stocks For Investors In 2026
Published: January 16, 2026 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry is set to reach new horizons in 2026. More companies are coming together to take the industry to a level yet to be seen. With bigger and better partnerships taking effect this year, consumer demand should go beyond mere satisfaction. Along with the political climate around cannabis in the US, marijuana stocks could see a jump from all of the above. 2026 brings in a large amount of positive speculation with all that is going on.
Read More
Weekly Jobless Claims Come in Muted
Published: January 08, 2026 by: Zacks Investment Research
Sentiment: Neutral
Weekly Jobless Claims Come in Muted.
Read More
Tilray Q2: High Hopes or Harsh Reality?
Published: January 06, 2026 by: Benzinga
Sentiment: Neutral
As Canadian cannabis king Tilray Brands, Inc. (NASDAQ: TLRY) prepares to report its fiscal Q2 2026 results on Thursday, the company stands at a crossroads.
Read More
Tilray Brands Readies for Q2 Earnings: Here's What You Should Know
Published: January 06, 2026 by: Zacks Investment Research
Sentiment: Positive
TLRY's faces margin pressure in cannabis and beverages, but management sees a beverage turnaround and wellness strength cushioning quarterly results.
Read More
How Long Will the Cannabis Stock Rally Last?
Published: January 01, 2026 by: The Motley Fool
Sentiment: Positive
Cannabis stocks have had significant momentum due to positive regulatory changes in the U.S. However, this momentum is likely to be relatively short-lived. These 10 Stocks Could Mint the Next Wave of Millionaires ›
Read More
Riding the Marijuana Reclassification Wave: 3 Stocks to Watch in 2026
Published: December 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Marijuana's potential move to Schedule III could reshape cannabis economics, putting CRON, VFF and TLRY in focus for 2026 investors.
Read More
The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations
Published: December 30, 2025 by: MarketBeat
Sentiment: Neutral
On Dec. 18, 2025, President Trump signed a pivotal Executive Order directing the Attorney General to expedite the rescheduling of cannabis. By all traditional metrics, this political victory should have sparked a sustained rally.
Read More
3 Marijuana Stocks To Watch In 2026
Published: December 26, 2025 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. After years of regulatory uncertainty, capital constraints, and volatile price action, relief is being shown. The legal cannabis market is showing clear signs of structural improvement driven by policy reform, consolidation, and expanding global demand.
Read More
3 Top Marijuana Stocks After Cannabis Gets Rescheduled
Published: December 22, 2025 by: MarijuanaStocks
Sentiment: Positive
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling fundamentally changes how the plant is viewed under federal law. With meaningful implications for operators, investors, and public markets. For the cannabis industry, the most immediate impact is financial. A shift to Schedule III would effectively eradicate IRS Section 280E. This is a law that currently prevents cannabis businesses from deducting standard operating expenses.
Read More
Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026
Published: December 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK and LEAMINGTON, Ontario, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the second fiscal quarter which ended November 30, 2025, after the financial markets close on Thursday, January 8, 2026.
Read More
3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III?
Published: December 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff highlights how fragile sentiment in cannabis stock remains, even amid policy progress. Further volatility is possible if regulatory implementation drags on or if broader market risk appetite weakens.
Read More
Trump signs executive order to reschedule cannabis. Here's what's next
Published: December 19, 2025 by: CNBC Television
Sentiment: Positive
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted the President's stance on the drug.
Read More
Trump just legalized marijuana nationwide — here's why potheads are rejoicing
Published: December 19, 2025 by: New York Post
Sentiment: Positive
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government.
Read More
About Tilray Brands, Inc. (TLRY)
- IPO Date 2018-07-19
- Website https://www.tilray.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Irwin David Simon
- Employees 2650